If you have ever met Deborah Viscardi Samet, you know that she brightens any room she walks into with her beautiful smile, positive attitude and welcoming presence. Debbie is a loving mother, devoted wife and friend, and a legendary chef. If you ask Debbie what she is proud of, she will show you a picture of her children, Dave and Dana, laughing or making funny faces.
In 2011, Debbie and her family were heartbroken to learn that she has Multiple Myeloma.
About Multiple Myeloma
Multiple myeloma is an incurable and fatal blood cancer. The five-year relative survival rate for multiple myeloma is approximately 41 percent, one of the lowest of all cancers. In 2013, more than 20,000 adults in the United States will be diagnosed with multiple myeloma and nearly 11,000 people are predicted to die from the disease.
About This Fundraiser
Debbie, David, and Dana’s husband, Eric, pledged to run up the empire state building to support the Multiple Myeloma Research Foundation. In 2013, Debbie ran 1576 steps in less than 22 minutes and raised $3650. “Stand Up for Debbie: A Comedy Show and Cancer Fundraiser” will enable Debbie and her sons to participate in their second MMRF Empire State Building Run Up. This comedy show honors not only Debbie’s strength of character, but her love of laughter.
Thank you for joining us in our mission to help MMRF improve treatment and research for the cure for Multiple Myeloma. All ticket and raffle sales will be donated to the MMRF.
You can support MMRF through Debbie or her sons’ Empire State Building Run Up pages:
Help Debbie Run Up the Empire State Building for MMRF: http://www.active.com/donate/2014MMRFRunUp/RUDSamet
Help Dave Run Up the Empire State Building for Debbie and MMRF:
Help Eric Run Up the Empire State Building for Debbie and MMRF:
About the Multiple Myeloma Research Foundation (MMRF)
The Multiple Myeloma Research Foundation (MMRF) was established in 1998 as a 501(c)(3) non-profit organization. The mission of the MMRF is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure. As the world's number-one private funder of multiple myeloma research, the MMRF has raised over $225 million since its inception and directs 90% of total budget to research and related programming. As a result, the MMRF has been awarded Charity Navigator’s coveted four-star rating for 10 consecutive years, the highest designation for outstanding fiscal responsibility and exceptional efficiency. The work of the MMRF contributed to the FDA approval of 6 drugs to fight multiple myeloma - a track record unparalleled in oncology. Due to their success in myeloma, these same drugs are now being explored as potential treatments for more than 30 other cancers.